Verana Health Expands Clinical Trial Tools with Real World Data Integration
Verana Health announced in a press release new features for its Site Explorer and Verana Trial Connect applications to improve site selection and patient enrollment in clinical trials. The tools now provide full process visibility for sponsors and contract research organizations through real time dashboards that display deidentified screening activity and site performance.
The Site Explorer platform helps sponsors locate medical practices with patient populations that match their study criteria and shows how inclusion and exclusion rules affect eligible trial populations. Verana Trial Connect uses data from electronic health records to identify potential participants and automate eligibility checks, reducing manual review and accelerating the prescreening process.
Verana Health’s data access comes through partnerships with the American Academy of Ophthalmology IRIS Registry and the American Urological Association Quality Registry. These collaborations give the company deidentified health records for more than 95 million patients across over 3,200 practices, refreshed regularly to ensure current insights for trial planning and execution.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Verana Health and Bitfount Detail AI Prescreening for Eye Trials
Suvoda Updates Clinical Trial Platform With AI and Unified Access
TRI Launches TRIAL.OS for Clinical Trial Management
Truven launches MarketScan Snapshot for healthcare data checks
Zivian Health Launches Elevate AI Chart Review Tool
Daily AI Brief: the AI news that matters, in your inbox.